Atlas Trials

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer

Clinical trial NCT01151449 · TERMINATED

Trial details

NCT number
NCT01151449
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerMale Breast CancerProgesterone Receptor-negative Breast CancerRecurrent Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerTriple-negative Breast Cancer
Start date
2010-06-01
Primary completion
2012-07-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.